Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+) (NCT06472206)
🩺 Plain-English Summary (8th-Grade Level)
Although global efforts have been made to end the HIV epidemic, there are still some gaps in HIV testing, antiretroviral therapy (ART) adherence, and viral suppression (VS) among people with HIV (PWH). These gaps are particularly prominent in the Deep South of the United States (US), where PWH face challenges in accessing healthcare services. In response, a team of experienced researchers has developed and tested the Community Health Workers And MHealth to ImProve Viral Suppression (CHAMPS) intervention. This intervention uses mobile health (mHealth) technology and a team of community health workers (CHW) to design an intervention to improve ART adherence and VS. The CHAMPS+ intervention adds a CHW delivered supportive risk reduction counseling during periods of non-suppression to prevent HIV transmission. The study will engage the participants by developing culturally relevant materials and retention strategies, evaluating the clinical effectiveness and sustainability of the intervention in Deep South settings, and assessing regionalized implementation factors. Ultimately, the study will test the effectiveness of CHAMPS+ on ART adherence and viral load suppression for PWH in Alabama, Louisiana, and Mississippi.
Who can join: Review the eligibility criteria below.
Location: Health Services Center, Inc. — Hobson City, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- Health Services Center, Inc. — Hobson City, Alabama
- Unity Wellness Center — Opelika, Alabama
- Louisiana State University Health Sciences Center in New Orleans — New Orleans, Louisiana
- Tulane University — New Orleans, Louisiana
- University of Mississippi Medical Center — Jackson, Mississippi
📞 Contact the Study Coordinator
Phone: (212) 342-6886
Email: rb897@columbia.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HIV/AIDS
- Optimizing Tobacco Use Treatment for PLWHA — Chicago, Illinois
- Intervention for Virologic Suppression in Youth — San Francisco, California
- ResIlience-based Stigma REdUction Program ("Rise-up") — Columbia, South Carolina
- Effects of Semaglutide in HIV-Associated Lipohypertrophy — Cleveland, Ohio
- Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana — Philadelphia, Pennsylvania
- The Dreamer Girls Project: Adaptation of SISTA/SIHLE for HIV/AIDS and Substance Abuse Prevention Among Black Adolescent Girls — Paterson, New Jersey
Explore by condition: All HIV/AIDS clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.